メタボロミクスバイオマーカーの世界市場 2020年：企業別、地域別、種類・用途別

• 英文タイトル：Global Metabolomics Biomarker Market 2020 by Company, Regions, Type and Application, Forecast to 2025

• レポートコード：D005-00652 • 出版社/出版日：GlobalInfoResearch / 2020年5月29日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、103ページ • 納品方法：Eメール • 産業分類：医療・製薬

• 販売価格（消費税別）

Single User	￥515,040 (USD3,480)	▷ お問い合わせ
Multi User	￥772,560 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,030,080 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本調査レポートでは、メタボロミクスバイオマーカーの世界市場を広く調査・分析し、今後の市場展望をまとめております。メタボロミクスバイオマーカーの種類別市場規模（ガスクロマトグラフィー、高速液体クロマトグラフィー、超高速液体クロマトグラフィー、核磁気共鳴、質量分析、表面質量分析、バイオインフォマティクス）、用途別市場規模（毒性試験、薬物検査、がん、心臓血管障害、神経障害、先天性代謝異常）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Biocrates Life Sciences、Metabolomic Diagnostics、Creative Proteomics、Biomark Diagnostics、Merck、Chenomx、Ovid Therapeutics、Human Metabolome Technologies、Evotec、Metabolon ・地域別グローバル市場分析 2015年-2020年 ・メタボロミクスバイオマーカーの北米市場（アメリカ、カナダ、メキシコ） ・メタボロミクスバイオマーカーのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・メタボロミクスバイオマーカーのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・メタボロミクスバイオマーカーの南米市場（ブラジル、アルゼンチン） ・メタボロミクスバイオマーカーの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：ガスクロマトグラフィー、高速液体クロマトグラフィー、超高速液体クロマトグラフィー、核磁気共鳴、質量分析、表面質量分析、バイオインフォマティクス ・用途別分析：毒性試験、薬物検査、がん、心臓血管障害、神経障害、先天性代謝異常 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論

Market Overview
The global Metabolomics Biomarker market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Metabolomics Biomarker market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Metabolomics Biomarker market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Metabolomics Biomarker market has been segmented into:
Gas chromatography
High-performance liquid chromatography
Ultra-performance liquid chromatography
Nuclear magnetic resonance
Mass spectrometry
Surface-based mass analysis
Bioinformatics

By Application, Metabolomics Biomarker has been segmented into:
Toxicological studies
Drug testing
Cancer
Cardiovascular disorders
Neurological disorders
Inborn errors of metabolism

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Metabolomics Biomarker market presented in the report. This section sheds light on the sales growth of different regional and country-level Metabolomics Biomarker markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Metabolomics Biomarker market.

The report offers in-depth assessment of the growth and other aspects of the Metabolomics Biomarker market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Metabolomics Biomarker Market Share Analysis
Metabolomics Biomarker competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Metabolomics Biomarker sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Metabolomics Biomarker sales, revenue and market share for each player covered in this report.

The major players covered in Metabolomics Biomarker are:
Biocrates Life Sciences
Metabolomic Diagnostics
Creative Proteomics
Biomark Diagnostics
Merck
Chenomx
Ovid Therapeutics
Human Metabolome Technologies
Evotec
Metabolon

レポート目次

---

Table of Contents

1 Metabolomics Biomarker Market Overview
1.1 Product Overview and Scope of Metabolomics Biomarker
1.2 Classification of Metabolomics Biomarker by Type
1.2.1 Global Metabolomics Biomarker Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Metabolomics Biomarker Revenue Market Share by Type in 2019
1.2.3 Gas chromatography
1.2.4 High-performance liquid chromatography
1.2.5 Ultra-performance liquid chromatography
1.2.6 Nuclear magnetic resonance
1.2.7 Mass spectrometry
1.2.8 Surface-based mass analysis
1.2.9 Bioinformatics
1.3 Global Metabolomics Biomarker Market by Application
1.3.1 Overview: Global Metabolomics Biomarker Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Toxicological studies
1.3.3 Drug testing
1.3.4 Cancer
1.3.5 Cardiovascular disorders
1.3.6 Neurological disorders
1.3.7 Inborn errors of metabolism
1.4 Global Metabolomics Biomarker Market by Regions
1.4.1 Global Metabolomics Biomarker Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Metabolomics Biomarker (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Metabolomics Biomarker Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Metabolomics Biomarker Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Metabolomics Biomarker Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Metabolomics Biomarker Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Metabolomics Biomarker Status and Prospect (2015-2025)
2 Company Profiles
2.1 Biocrates Life Sciences
2.1.1 Biocrates Life Sciences Details
2.1.2 Biocrates Life Sciences Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Biocrates Life Sciences SWOT Analysis
2.1.4 Biocrates Life Sciences Product and Services
2.1.5 Biocrates Life Sciences Metabolomics Biomarker Revenue, Gross Margin and Market Share (2018-2019)
2.2 Metabolomic Diagnostics
2.2.1 Metabolomic Diagnostics Details
2.2.2 Metabolomic Diagnostics Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Metabolomic Diagnostics SWOT Analysis
2.2.4 Metabolomic Diagnostics Product and Services
2.2.5 Metabolomic Diagnostics Metabolomics Biomarker Revenue, Gross Margin and Market Share (2018-2019)
2.3 Creative Proteomics
2.3.1 Creative Proteomics Details
2.3.2 Creative Proteomics Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Creative Proteomics SWOT Analysis
2.3.4 Creative Proteomics Product and Services
2.3.5 Creative Proteomics Metabolomics Biomarker Revenue, Gross Margin and Market Share (2018-2019)
2.4 Biomark Diagnostics
2.4.1 Biomark Diagnostics Details
2.4.2 Biomark Diagnostics Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Biomark Diagnostics SWOT Analysis
2.4.4 Biomark Diagnostics Product and Services
2.4.5 Biomark Diagnostics Metabolomics Biomarker Revenue, Gross Margin and Market Share (2018-2019)
2.5 Merck
2.5.1 Merck Details
2.5.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Merck SWOT Analysis
2.5.4 Merck Product and Services
2.5.5 Merck Metabolomics Biomarker Revenue, Gross Margin and Market Share (2018-2019)
2.6 Chenomx
2.6.1 Chenomx Details
2.6.2 Chenomx Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Chenomx SWOT Analysis
2.6.4 Chenomx Product and Services
2.6.5 Chenomx Metabolomics Biomarker Revenue, Gross Margin and Market Share (2018-2019)
2.7 Ovid Therapeutics
2.7.1 Ovid Therapeutics Details
2.7.2 Ovid Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Ovid Therapeutics SWOT Analysis
2.7.4 Ovid Therapeutics Product and Services
2.7.5 Ovid Therapeutics Metabolomics Biomarker Revenue, Gross Margin and Market Share (2018-2019)
2.8 Human Metabolome Technologies
2.8.1 Human Metabolome Technologies Details
2.8.2 Human Metabolome Technologies Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Human Metabolome Technologies SWOT Analysis
2.8.4 Human Metabolome Technologies Product and Services
2.8.5 Human Metabolome Technologies Metabolomics Biomarker Revenue, Gross Margin and Market Share (2018-2019)
2.9 Evotec
2.9.1 Evotec Details
2.9.2 Evotec Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Evotec SWOT Analysis
2.9.4 Evotec Product and Services
2.9.5 Evotec Metabolomics Biomarker Revenue, Gross Margin and Market Share (2018-2019)
2.10 Metabolon
2.10.1 Metabolon Details
2.10.2 Metabolon Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Metabolon SWOT Analysis
2.10.4 Metabolon Product and Services
2.10.5 Metabolon Metabolomics Biomarker Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Metabolomics Biomarker Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Metabolomics Biomarker Players Market Share
3.2.2 Top 10 Metabolomics Biomarker Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Metabolomics Biomarker Revenue and Market Share by Regions
4.2 North America Metabolomics Biomarker Revenue and Growth Rate (2015-2020)
4.3 Europe Metabolomics Biomarker Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Metabolomics Biomarker Revenue and Growth Rate (2015-2020)
4.5 South America Metabolomics Biomarker Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Metabolomics Biomarker Revenue and Growth Rate (2015-2020)
5 North America Metabolomics Biomarker Revenue by Countries
5.1 North America Metabolomics Biomarker Revenue by Countries (2015-2020)
5.2 USA Metabolomics Biomarker Revenue and Growth Rate (2015-2020)
5.3 Canada Metabolomics Biomarker Revenue and Growth Rate (2015-2020)
5.4 Mexico Metabolomics Biomarker Revenue and Growth Rate (2015-2020)
6 Europe Metabolomics Biomarker Revenue by Countries
6.1 Europe Metabolomics Biomarker Revenue by Countries (2015-2020)
6.2 Germany Metabolomics Biomarker Revenue and Growth Rate (2015-2020)
6.3 UK Metabolomics Biomarker Revenue and Growth Rate (2015-2020)
6.4 France Metabolomics Biomarker Revenue and Growth Rate (2015-2020)
6.5 Russia Metabolomics Biomarker Revenue and Growth Rate (2015-2020)
6.6 Italy Metabolomics Biomarker Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Metabolomics Biomarker Revenue by Countries
7.1 Asia-Pacific Metabolomics Biomarker Revenue by Countries (2015-2020)
7.2 China Metabolomics Biomarker Revenue and Growth Rate (2015-2020)
7.3 Japan Metabolomics Biomarker Revenue and Growth Rate (2015-2020)
7.4 Korea Metabolomics Biomarker Revenue and Growth Rate (2015-2020)
7.5 India Metabolomics Biomarker Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Metabolomics Biomarker Revenue and Growth Rate (2015-2020)
8 South America Metabolomics Biomarker Revenue by Countries
8.1 South America Metabolomics Biomarker Revenue by Countries (2015-2020)
8.2 Brazil Metabolomics Biomarker Revenue and Growth Rate (2015-2020)
8.3 Argentina Metabolomics Biomarker Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Metabolomics Biomarker by Countries
9.1 Middle East & Africa Metabolomics Biomarker Revenue by Countries (2015-2020)
9.2 Saudi Arabia Metabolomics Biomarker Revenue and Growth Rate (2015-2020)
9.3 UAE Metabolomics Biomarker Revenue and Growth Rate (2015-2020)
9.4 Egypt Metabolomics Biomarker Revenue and Growth Rate (2015-2020)
9.5 South Africa Metabolomics Biomarker Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Metabolomics Biomarker Revenue and Market Share by Type (2015-2020)
10.2 Global Metabolomics Biomarker Market Forecast by Type (2019-2024)
10.3 Gas chromatography Revenue Growth Rate (2015-2025)
10.4 High-performance liquid chromatography Revenue Growth Rate (2015-2025)
10.5 Ultra-performance liquid chromatography Revenue Growth Rate (2015-2025)
10.6 Nuclear magnetic resonance Revenue Growth Rate (2015-2025)
10.7 Mass spectrometry Revenue Growth Rate (2015-2025)
10.8 Surface-based mass analysis Revenue Growth Rate (2015-2025)
10.9 Bioinformatics Revenue Growth Rate (2015-2025)
11 Global Metabolomics Biomarker Market Segment by Application
11.1 Global Metabolomics Biomarker Revenue Market Share by Application (2015-2020)
11.2 Metabolomics Biomarker Market Forecast by Application (2019-2024)
11.3 Toxicological studies Revenue Growth (2015-2020)
11.4 Drug testing Revenue Growth (2015-2020)
11.5 Cancer Revenue Growth (2015-2020)
11.6 Cardiovascular disorders Revenue Growth (2015-2020)
11.7 Neurological disorders Revenue Growth (2015-2020)
11.8 Inborn errors of metabolism Revenue Growth (2015-2020)
12 Global Metabolomics Biomarker Market Size Forecast (2021-2025)
12.1 Global Metabolomics Biomarker Market Size Forecast (2021-2025)
12.2 Global Metabolomics Biomarker Market Forecast by Regions (2021-2025)
12.3 North America Metabolomics Biomarker Revenue Market Forecast (2021-2025)
12.4 Europe Metabolomics Biomarker Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Metabolomics Biomarker Revenue Market Forecast (2021-2025)
12.6 South America Metabolomics Biomarker Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Metabolomics Biomarker Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables

Table 1. Global Metabolomics Biomarker Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Metabolomics Biomarker by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Metabolomics Biomarker Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Metabolomics Biomarker Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Biocrates Life Sciences Corporate Information, Location and Competitors
Table 6. Biocrates Life Sciences Metabolomics Biomarker Major Business
Table 7. Biocrates Life Sciences Metabolomics Biomarker Total Revenue (USD Million) (2017-2018)
Table 8. Biocrates Life Sciences SWOT Analysis
Table 9. Biocrates Life Sciences Metabolomics Biomarker Product and Solutions
Table 10. Biocrates Life Sciences Metabolomics Biomarker Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Metabolomic Diagnostics Corporate Information, Location and Competitors
Table 12. Metabolomic Diagnostics Metabolomics Biomarker Major Business
Table 13. Metabolomic Diagnostics Metabolomics Biomarker Total Revenue (USD Million) (2018-2019)
Table 14. Metabolomic Diagnostics SWOT Analysis
Table 15. Metabolomic Diagnostics Metabolomics Biomarker Product and Solutions
Table 16. Metabolomic Diagnostics Metabolomics Biomarker Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Creative Proteomics Corporate Information, Location and Competitors
Table 18. Creative Proteomics Metabolomics Biomarker Major Business
Table 19. Creative Proteomics Metabolomics Biomarker Total Revenue (USD Million) (2017-2018)
Table 20. Creative Proteomics SWOT Analysis
Table 21. Creative Proteomics Metabolomics Biomarker Product and Solutions
Table 22. Creative Proteomics Metabolomics Biomarker Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Biomark Diagnostics Corporate Information, Location and Competitors
Table 24. Biomark Diagnostics Metabolomics Biomarker Major Business
Table 25. Biomark Diagnostics Metabolomics Biomarker Total Revenue (USD Million) (2017-2018)
Table 26. Biomark Diagnostics SWOT Analysis
Table 27. Biomark Diagnostics Metabolomics Biomarker Product and Solutions
Table 28. Biomark Diagnostics Metabolomics Biomarker Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Merck Corporate Information, Location and Competitors
Table 30. Merck Metabolomics Biomarker Major Business
Table 31. Merck Metabolomics Biomarker Total Revenue (USD Million) (2017-2018)
Table 32. Merck SWOT Analysis
Table 33. Merck Metabolomics Biomarker Product and Solutions
Table 34. Merck Metabolomics Biomarker Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Chenomx Corporate Information, Location and Competitors
Table 36. Chenomx Metabolomics Biomarker Major Business
Table 37. Chenomx Metabolomics Biomarker Total Revenue (USD Million) (2017-2018)
Table 38. Chenomx SWOT Analysis
Table 39. Chenomx Metabolomics Biomarker Product and Solutions
Table 40. Chenomx Metabolomics Biomarker Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Ovid Therapeutics Corporate Information, Location and Competitors
Table 42. Ovid Therapeutics Metabolomics Biomarker Major Business
Table 43. Ovid Therapeutics Metabolomics Biomarker Total Revenue (USD Million) (2017-2018)
Table 44. Ovid Therapeutics SWOT Analysis
Table 45. Ovid Therapeutics Metabolomics Biomarker Product and Solutions
Table 46. Ovid Therapeutics Metabolomics Biomarker Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Human Metabolome Technologies Corporate Information, Location and Competitors
Table 48. Human Metabolome Technologies Metabolomics Biomarker Major Business
Table 49. Human Metabolome Technologies Metabolomics Biomarker Total Revenue (USD Million) (2017-2018)
Table 50. Human Metabolome Technologies SWOT Analysis
Table 51. Human Metabolome Technologies Metabolomics Biomarker Product and Solutions
Table 52. Human Metabolome Technologies Metabolomics Biomarker Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Evotec Corporate Information, Location and Competitors
Table 54. Evotec Metabolomics Biomarker Major Business
Table 55. Evotec Metabolomics Biomarker Total Revenue (USD Million) (2017-2018)
Table 56. Evotec SWOT Analysis
Table 57. Evotec Metabolomics Biomarker Product and Solutions
Table 58. Evotec Metabolomics Biomarker Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Metabolon Corporate Information, Location and Competitors
Table 60. Metabolon Metabolomics Biomarker Major Business
Table 61. Metabolon Metabolomics Biomarker Total Revenue (USD Million) (2017-2018)
Table 62. Metabolon SWOT Analysis
Table 63. Metabolon Metabolomics Biomarker Product and Solutions
Table 64. Metabolon Metabolomics Biomarker Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Global Metabolomics Biomarker Revenue (Million USD) by Players (2015-2020)
Table 66. Global Metabolomics Biomarker Revenue Share by Players (2015-2020)
Table 67. Global Metabolomics Biomarker Revenue (Million USD) by Regions (2015-2020)
Table 68. Global Metabolomics Biomarker Revenue Market Share by Regions (2015-2020)
Table 69. North America Metabolomics Biomarker Revenue by Countries (2015-2020)
Table 70. North America Metabolomics Biomarker Revenue Market Share by Countries (2015-2020)
Table 71. Europe Metabolomics Biomarker Revenue (Million USD) by Countries (2015-2020)
Table 72. Asia-Pacific Metabolomics Biomarker Revenue (Million USD) by Countries (2015-2020)
Table 73. South America Metabolomics Biomarker Revenue by Countries (2015-2020)
Table 74. South America Metabolomics Biomarker Revenue Market Share by Countries (2015-2020)
Table 75. Middle East and Africa Metabolomics Biomarker Revenue (Million USD) by Countries (2015-2020)
Table 76. Middle East and Africa Metabolomics Biomarker Revenue Market Share by Countries (2015-2020)
Table 77. Global Metabolomics Biomarker Revenue (Million USD) by Type (2015-2020)
Table 78. Global Metabolomics Biomarker Revenue Share by Type (2015-2020)
Table 79. Global Metabolomics Biomarker Revenue Forecast by Type (2021-2025)
Table 80. Global Metabolomics Biomarker Revenue by Application (2015-2020)
Table 81. Global Metabolomics Biomarker Revenue Share by Application (2015-2020)
Table 82. Global Metabolomics Biomarker Revenue Forecast by Application (2021-2025)
Table 83. Global Metabolomics Biomarker Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Metabolomics Biomarker Picture
Figure 2. Global Metabolomics Biomarker Revenue Market Share by Type in 2019
Figure 3. Gas chromatography Picture
Figure 4. High-performance liquid chromatography Picture
Figure 5. Ultra-performance liquid chromatography Picture
Figure 6. Nuclear magnetic resonance Picture
Figure 7. Mass spectrometry Picture
Figure 8. Surface-based mass analysis Picture
Figure 9. Bioinformatics Picture
Figure 10. Metabolomics Biomarker Revenue Market Share by Application in 2019
Figure 11. Toxicological studies Picture
Figure 12. Drug testing Picture
Figure 13. Cancer Picture
Figure 14. Cardiovascular disorders Picture
Figure 15. Neurological disorders Picture
Figure 16. Inborn errors of metabolism Picture
Figure 17. Global Metabolomics Biomarker Revenue (USD Million) and Growth Rate (2015-2025)
Figure 18. North America Metabolomics Biomarker Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Europe Metabolomics Biomarker Revenue (Million USD) and Growth Rate (2015-2025)
Figure 20. Asia-Pacific Metabolomics Biomarker Revenue (Million USD) and Growth Rate (2015-2025)
Figure 21. South America Metabolomics Biomarker Revenue (Million USD) and Growth Rate (2015-2025)
Figure 22. Middle East and Africa Metabolomics Biomarker Revenue (Million USD) and Growth Rate (2015-2025)
Figure 23. Global Metabolomics Biomarker Revenue (Million USD) and Growth Rate (2015-2025)
Figure 24. Global Metabolomics Biomarker Revenue Share by Players in 2019
Figure 25. Global Top 5 Players Metabolomics Biomarker Revenue Market Share in 2019
Figure 26. Global Top 10 Players Metabolomics Biomarker Revenue Market Share in 2019
Figure 27. Key Players Market Share Trend
Figure 28. Global Metabolomics Biomarker Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 29. Global Metabolomics Biomarker Revenue Market Share by Regions (2015-2020)
Figure 30. Global Metabolomics Biomarker Revenue Market Share by Regions in 2018
Figure 31. North America Metabolomics Biomarker Revenue and Growth Rate (2015-2020)
Figure 32. Europe Metabolomics Biomarker Revenue and Growth Rate (2015-2020)
Figure 33. Asia-Pacific Metabolomics Biomarker Revenue and Growth Rate (2015-2020)
Figure 34. South America Metabolomics Biomarker Revenue and Growth Rate (2015-2020)
Figure 35. Middle East and Africa Metabolomics Biomarker Revenue and Growth Rate (2015-2020)
Figure 36. North America Metabolomics Biomarker Revenue Market Share by Countries (2015-2020)
Figure 37. North America Metabolomics Biomarker Revenue Market Share by Countries in 2019
Figure 38. USA Metabolomics Biomarker Revenue and Growth Rate (2015-2020)
Figure 39. Canada Metabolomics Biomarker Revenue and Growth Rate (2015-2020)
Figure 40. Mexico Metabolomics Biomarker Revenue and Growth Rate (2015-2020)
Figure 41. Europe Metabolomics Biomarker Revenue Market Share by Countries (2015-2020)
Figure 42. Europe Metabolomics Biomarker Revenue Market Share by Countries in 2019
Figure 43. Germany Metabolomics Biomarker Revenue and Growth Rate (2015-2020)
Figure 44. UK Metabolomics Biomarker Revenue and Growth Rate (2015-2020)
Figure 45. France Metabolomics Biomarker Revenue and Growth Rate (2015-2020)
Figure 46. Russia Metabolomics Biomarker Revenue and Growth Rate (2015-2020)
Figure 47. Italy Metabolomics Biomarker Revenue and Growth Rate (2015-2020)
Figure 48. Asia-Pacific Metabolomics Biomarker Revenue Market Share by Countries (2015-2020)
Figure 49. Asia-Pacific Metabolomics Biomarker Revenue Market Share by Countries in 2019
Figure 50. China Metabolomics Biomarker Revenue and Growth Rate (2015-2020)
Figure 51. Japan Metabolomics Biomarker Revenue and Growth Rate (2015-2020)
Figure 52. Korea Metabolomics Biomarker Revenue and Growth Rate (2015-2020)
Figure 53. India Metabolomics Biomarker Revenue and Growth Rate (2015-2020)
Figure 54. Southeast Asia Metabolomics Biomarker Revenue and Growth Rate (2015-2020)
Figure 55. South America Metabolomics Biomarker Revenue Market Share by Countries (2015-2020)
Figure 56. South America Metabolomics Biomarker Revenue Market Share by Countries in 2019
Figure 57. Brazil Metabolomics Biomarker Revenue and Growth Rate (2015-2020)
Figure 58. Argentina Metabolomics Biomarker Revenue and Growth Rate (2015-2020)
Figure 59. Middle East and Africa Metabolomics Biomarker Revenue Market Share by Countries (2015-2020)
Figure 60. Middle East and Africa Metabolomics Biomarker Revenue Market Share by Countries in 2019
Figure 61. Saudi Arabia Metabolomics Biomarker Revenue and Growth Rate (2015-2020)
Figure 62. UAE Metabolomics Biomarker Revenue and Growth Rate (2015-2020)
Figure 63. Egypt Metabolomics Biomarker Revenue and Growth Rate (2015-2020)
Figure 64. South Africa Metabolomics Biomarker Revenue and Growth Rate (2015-2020)
Figure 65. Global Metabolomics Biomarker Revenue Share by Type (2015-2020)
Figure 66. Global Metabolomics Biomarker Revenue Share by Type in 2019
Figure 67. Global Metabolomics Biomarker Market Share Forecast by Type (2021-2025)
Figure 68. Global Gas chromatography Revenue Growth Rate (2015-2020)
Figure 69. Global High-performance liquid chromatography Revenue Growth Rate (2015-2020)
Figure 70. Global Ultra-performance liquid chromatography Revenue Growth Rate (2015-2020)
Figure 71. Global Nuclear magnetic resonance Revenue Growth Rate (2015-2020)
Figure 72. Global Mass spectrometry Revenue Growth Rate (2015-2020)
Figure 73. Global Surface-based mass analysis Revenue Growth Rate (2015-2020)
Figure 74. Global Bioinformatics Revenue Growth Rate (2015-2020)
Figure 75. Global Metabolomics Biomarker Revenue Share by Application (2015-2020)
Figure 76. Global Metabolomics Biomarker Revenue Share by Application in 2019
Figure 77. Global Metabolomics Biomarker Market Share Forecast by Application (2021-2025)
Figure 78. Global Toxicological studies Revenue Growth Rate (2015-2020)
Figure 79. Global Drug testing Revenue Growth Rate (2015-2020)
Figure 80. Global Cancer Revenue Growth Rate (2015-2020)
Figure 81. Global Cardiovascular disorders Revenue Growth Rate (2015-2020)
Figure 82. Global Neurological disorders Revenue Growth Rate (2015-2020)
Figure 83. Global Inborn errors of metabolism Revenue Growth Rate (2015-2020)
Figure 84. Global Metabolomics Biomarker Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 85. Global Metabolomics Biomarker Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 86. Global Metabolomics Biomarker Revenue Market Share Forecast by Regions (2021-2025)
Figure 87. North America Metabolomics Biomarker Revenue Market Forecast (2021-2025)
Figure 88. Europe Metabolomics Biomarker Revenue Market Forecast (2021-2025)
Figure 89. Asia-Pacific Metabolomics Biomarker Revenue Market Forecast (2021-2025)
Figure 90. South America Metabolomics Biomarker Revenue Market Forecast (2021-2025)
Figure 91. Middle East and Africa Metabolomics Biomarker Revenue Market Forecast (2021-2025)
Figure 92. Sales Channel: Direct Channel vs Indirect Channel

---